Richard Castledine

Dr. Richard Castledine

Head of Operations - Alnwick, UK

About

Richard Castledine is responsible for the overall leadership responsibility for drug product and drug substance operations, project management, isotope labelling, quality control and bioanalysis services at our Alnwick, UK facility.

Richard has 15 years of experience in the pharmaceutical and contract development industries. Following the completion of his PhD, he worked briefly as a medicinal chemist before moving into process chemistry. Richard has led process development of over 25 programs at different stages of development ranging from pre-clinical and Phase I to process validation. 

He holds a PhD in synthetic organic chemistry from the University of Nottingham.

Expertise & focus areas
Nottingham_Formulation_Scientists
Drug Substance, Dr. Richard Castledine

How Can Drug Developers Overcome API Synthesis Challenges in Drug Development?

Read More

Latest news from Quotient Sciences

More News
News & Announcements, Articles & Publications, John McDermott Q&A with Quotient Sciences’ John McDermott: Exploring the Benefits of Partnering with a CRDMO By: John McDermott
Read More
News & Announcements, Articles & Publications, Translational Pharmaceutics®, Dr. Asma Patel, Matt Paterson Dr. Asma Patel and Matt Pa­terson contribute to Drug Development & Delivery's special feature, 'Outsourcing Formulation Development & Manufacturing' By: Dr. Asma Patel and Matt Paterson
Read More
News & Announcements, Articles & Publications, commercial manufacturing, Dr. Helen Baker, Dr. Richard Castledine Dr. Helen Baker and Dr. Richard Castledine contribute to Pharmaceutical Technology's 'Poor API Quality Threatens a Healthy Supply' By: Dr. Helen Baker and Dr. Richard Castledine
Read More